Productivity losses & indirect costs after cardiovascular events V1.0
Research type
Research Study
Full title
Productivity losses and indirect costs after cardiovascular events in Europe
IRAS ID
204206
Contact name
Kornelia Kotseva
Contact email
Sponsor organisation
Amgen (Europe) GmbH
Duration of Study in the UK
0 years, 4 months, 31 days
Research summary
The purpose of this cross-sectional survey is to evaluate productivity loss and associated costs in Acute Coronary Syndrome (ACS) (including myocardial infarction and unstable angina), congestive heart failure (CHF), and stroke patients. The study will involve 1,200 cardiovascular patients from 12 European countries). The patients will be recruited through their physicians during a regular consultation visit 3-12 months after the index event. Data will be collected via a patient and a physician questionnaire (retrospective data collection), as well as through a physician logbook: the physicians will provide patients’ diagnoses, characteristics, and pertinent data from medical records and the patients will supply information about their absence from work and loss of productivity due to the cardiovascular event (using the iMTA Productivity Cost Questionnaire (iPCQ)). Patients’ responses are meant to provide information about absence from work and productivity loss that is normally not reflected in medical records. The participating physicians will be cardiologists and neurologists who routinely manage patients with the described cardiovascular events. One hundred patients are planned per country, distributed over 3 (big) hospitals (geographical spread), whereby in each participating hospital 1 cardiologist (ACS/CHF) and 1 neurologist are participating. The target is to have 11 recruited patients per neurologist and 22-23 recruited patients per cardiologist.
REC name
London - Central Research Ethics Committee
REC reference
16/LO/1529
Date of REC Opinion
13 Sep 2016
REC opinion
Further Information Favourable Opinion